US pharmacy pricing
Where to Find the Cheapest Alymsys Price
Lowest price found · US pharmacies
$2,813.16/fill
for Alymsys, across the pharmacies in our data
US pharmacy prices — 16ml of 400mg/16ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $2,813.16Lowest | $2,816.16 | $2,586.96 | |
| $2,813.16Lowest | $2,816.16 | $2,586.96 | |
| $2,952.88 | $2,955.88 | $2,586.96 | |
| $2,971.38 | $2,974.38 | $2,586.96 | |
| $3,037.37 | $3,040.37 | $2,586.96 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Alymsys.
Frequently asked questions
What's the cash price for Alymsys (Alymsys) in the US?
Our most recent US pharmacy data shows a low of roughly $2,813.16 for Alymsys with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.
Does Alymsys have a generic equivalent?
Generic and brand-name pricing for Alymsys is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
How does insurance affect the price of Alymsys?
The cost of Alymsys with insurance depends entirely on your specific plan's formulary, coverage rules, and copay structure. Contact your insurance provider for detailed information. If your plan does not cover the medication, a pharmacy savings card may provide an alternative way to access discounted pricing at participating pharmacies. These savings programs are generally available to anyone in the U.S. and Puerto Rico, including those with Medicare or Medicaid.
Is there a generic version of Alymsys available?
Alymsys is a biologic medication, a type of drug made from living cells, which are not described in terms of brand and generic. Instead, Alymsys is a biosimilar to the reference product, Avastin (bevacizumab). Biosimilars are highly similar to their reference product in terms of safety, purity, and effectiveness.
What is Alymsys and how is it used?
Alymsys (bevacizumab-maly) is a vascular endothelial growth factor (VEGF) inhibitor manufactured by Amneal Pharmaceuticals and approved by the FDA. It is used in combination with other therapies to treat several cancers, including metastatic colorectal cancer, certain non-squamous non-small cell lung cancers, recurrent glioblastoma, metastatic renal cell carcinoma, and specific cervical and ovarian cancers. It is administered by intravenous infusion in a clinical setting. Important safety considerations include the risk of fetal harm, requiring effective contraception during and for at least six months after treatment. Breastfeeding is not recommended during this same period. Inform your doctor of all medical conditions and medications, and discuss any planned surgeries, as treatment may need to be paused for at least 28 days before and after major procedures.